These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19159012)

  • 1. Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.
    Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Yin Z; Keller TH; Beer D; Patel V; Otting G; Caflisch A; Huang D
    PLoS Negl Trop Dis; 2009; 3(1):e356. PubMed ID: 19159012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen.
    Mueller NH; Pattabiraman N; Ansarah-Sobrinho C; Viswanathan P; Pierson TC; Padmanabhan R
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3385-93. PubMed ID: 18606844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput virtual screening lead to discovery of non-peptidic inhibitors of West Nile virus NS3 protease.
    Huang D
    Methods Mol Biol; 2012; 819():615-23. PubMed ID: 22183561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
    Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
    Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
    Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
    Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. West Nile Virus NS2B/NS3 protease as an antiviral target.
    Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
    Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a 3-Alkylpyridinium Compound from the Red Sea Sponge
    O'Rourke A; Kremb S; Duggan BM; Sioud S; Kharbatia N; Raji M; Emwas AH; Gerwick WH; Voolstra CR
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29912151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus.
    Johnston PA; Phillips J; Shun TY; Shinde S; Lazo JS; Huryn DM; Myers MC; Ratnikov BI; Smith JW; Su Y; Dahl R; Cosford ND; Shiryaev SA; Strongin AY
    Assay Drug Dev Technol; 2007 Dec; 5(6):737-50. PubMed ID: 18181690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor.
    Martinez AA; Espinosa BA; Adamek RN; Thomas BA; Chau J; Gonzalez E; Keppetipola N; Salzameda NT
    Eur J Med Chem; 2018 Sep; 157():1202-1213. PubMed ID: 30193218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase.
    Sidique S; Shiryaev SA; Ratnikov BI; Herath A; Su Y; Strongin AY; Cosford ND
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5773-7. PubMed ID: 19703770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
    Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
    Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease.
    Ezgimen M; Lai H; Mueller NH; Lee K; Cuny G; Ostrov DA; Padmanabhan R
    Antiviral Res; 2012 Apr; 94(1):18-24. PubMed ID: 22343093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the binding of peptidic West Nile virus NS2B-NS3 protease inhibitors by NMR.
    Kang C; Gayen S; Wang W; Severin R; Chen AS; Lim HA; Chia CS; Schüller A; Doan DN; Poulsen A; Hill J; Vasudevan SG; Keller TH
    Antiviral Res; 2013 Feb; 97(2):137-44. PubMed ID: 23211132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-β-lactam Inhibitors of Dengue and West Nile Virus NS2B-NS3 Protease Display Two Distinct Binding Modes.
    Dražić T; Kopf S; Corridan J; Leuthold MM; Bertoša B; Klein CD
    J Med Chem; 2020 Jan; 63(1):140-156. PubMed ID: 31804823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.
    Shiryaev SA; Cheltsov AV; Gawlik K; Ratnikov BI; Strongin AY
    Assay Drug Dev Technol; 2011 Feb; 9(1):69-78. PubMed ID: 21050032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.
    Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Otting G; Huang D; Caflisch A
    J Med Chem; 2009 Aug; 52(15):4860-8. PubMed ID: 19572550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds.
    de Oliveira AS; Gazolla PAR; Oliveira AFCDS; Pereira WL; de S Viol LC; Maia AFDS; Santos EG; da Silva ÍEP; Mendes TAO; da Silva AM; Dias RS; da Silva CC; Polêto MD; Teixeira RR; de Paula SO
    PLoS One; 2019; 14(9):e0223017. PubMed ID: 31557229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A FRET-based assay for the discovery of West Nile Virus NS2B-NS3 protease inhibitors.
    Adamek RN; Maniquis RV; Khakoo S; Bridges MD; Salzameda NT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4848-50. PubMed ID: 23886689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.